Milicent L. Cranor

2.5k total citations · 1 hit paper
21 papers, 1.8k citations indexed

About

Milicent L. Cranor is a scholar working on Pathology and Forensic Medicine, Oncology and Cancer Research. According to data from OpenAlex, Milicent L. Cranor has authored 21 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pathology and Forensic Medicine, 11 papers in Oncology and 10 papers in Cancer Research. Recurrent topics in Milicent L. Cranor's work include Breast Lesions and Carcinomas (9 papers), Breast Cancer Treatment Studies (9 papers) and Cancer and Skin Lesions (9 papers). Milicent L. Cranor is often cited by papers focused on Breast Lesions and Carcinomas (9 papers), Breast Cancer Treatment Studies (9 papers) and Cancer and Skin Lesions (9 papers). Milicent L. Cranor collaborates with scholars based in United States. Milicent L. Cranor's co-authors include Warren E. Enker, Tatyana Polyak, Howard T. Thaler, Paul Peter Rosen, Paul Peter Rosen, C M Powell, Bruce Youngson, Larry Norton, Patrick I. Borgen and Crispinita D. Arroyo and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

Milicent L. Cranor

21 papers receiving 1.7k citations

Hit Papers

Total mesorectal excision... 1995 2026 2005 2015 1995 100 200 300 400 500

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Milicent L. Cranor 985 846 804 607 513 21 1.8k
Robert W. McDivitt 519 0.5× 315 0.4× 1.2k 1.5× 553 0.9× 877 1.7× 29 1.8k
Marcia Edelweiss 392 0.4× 372 0.4× 484 0.6× 194 0.3× 484 0.9× 50 1.1k
Horacio Maluf 267 0.3× 280 0.3× 476 0.6× 400 0.7× 297 0.6× 50 930
Emmanuella Joseph 518 0.5× 411 0.5× 466 0.6× 119 0.2× 494 1.0× 12 1.1k
Iris M. C. van der Ploeg 697 0.7× 363 0.4× 435 0.5× 103 0.2× 538 1.0× 40 1.3k
C. Fisher 687 0.7× 158 0.2× 288 0.4× 198 0.3× 279 0.5× 16 1.1k
Fina Climent 515 0.5× 109 0.1× 738 0.9× 389 0.6× 308 0.6× 54 1.2k
Jia‐Huei Tsai 492 0.5× 490 0.6× 261 0.3× 107 0.2× 136 0.3× 54 1.2k
Giancarlo Zampi 473 0.5× 502 0.6× 415 0.5× 55 0.1× 151 0.3× 18 1.5k
Ivo Stárek 937 1.0× 1.0k 1.2× 270 0.3× 274 0.5× 38 0.1× 45 1.3k

Countries citing papers authored by Milicent L. Cranor

Since Specialization
Citations

This map shows the geographic impact of Milicent L. Cranor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Milicent L. Cranor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Milicent L. Cranor more than expected).

Fields of papers citing papers by Milicent L. Cranor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Milicent L. Cranor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Milicent L. Cranor. The network helps show where Milicent L. Cranor may publish in the future.

Co-authorship network of co-authors of Milicent L. Cranor

This figure shows the co-authorship network connecting the top 25 collaborators of Milicent L. Cranor. A scholar is included among the top collaborators of Milicent L. Cranor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Milicent L. Cranor. Milicent L. Cranor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Buchanan, Claire, Lauren R. Flynn, Melissa P. Murray, et al.. (2008). Is pleomorphic lobular carcinoma really a distinct clinical entity?. Journal of Surgical Oncology. 98(5). 314–317. 63 indexed citations
3.
Kattan, Michael W., Dilip D. Giri, Katherine S. Panageas, et al.. (2004). A tool for predicting breast carcinoma mortality in women who do not receive adjuvant therapy. Cancer. 101(11). 2509–2515. 34 indexed citations
4.
Mora, Jaume, et al.. (2000). Large cell non-Hodgkin lymphoma of childhood. Cancer. 88(1). 186–197. 36 indexed citations
5.
Rajan, Prabha, Milicent L. Cranor, & Paul Peter Rosen. (1998). Cystosarcoma Phyllodes in Adolescent Girls and Young Women. The American Journal of Surgical Pathology. 22(1). 64–69. 68 indexed citations
6.
Cranor, Milicent L., et al.. (1998). Metaplastic Carcinoma of the Breast With Osteocartilaginous Heterologous Elements. The American Journal of Surgical Pathology. 22(2). 188–194. 78 indexed citations
7.
McCormick, Beryl, et al.. (1997). A Comparative Study of Pure Tubular and Tubulolobular Carcinoma of the Breast. The American Journal of Surgical Pathology. 21(6). 653–657. 43 indexed citations
8.
Hamele‐Bena, Diane, Milicent L. Cranor, & Paul Peter Rosen. (1996). Mammary Mucocele-like Lesions. The American Journal of Surgical Pathology. 20(9). 1081–1085. 72 indexed citations
9.
Rosen, Paul Peter, Martin Lesser, Crispinita D. Arroyo, et al.. (1995). Immunohistochemical detection ofHER2/neu in patients with axillary lymph node negative breast carcinoma. A study of epidemiologic risk factors, histologic features, and prognosis. Cancer. 75(6). 1320–1326. 92 indexed citations
10.
Powell, C M, Milicent L. Cranor, & Paul Peter Rosen. (1995). Pseudoangiomatous Stromal Hyperplasia (PASH). The American Journal of Surgical Pathology. 19(3). 270–277. 172 indexed citations
11.
Rosen, Paul Peter, Martin Lesser, Crispinita D. Arroyo, et al.. (1995). p53 in node-negative breast carcinoma: an immunohistochemical study of epidemiologic risk factors, histologic features, and prognosis.. Journal of Clinical Oncology. 13(4). 821–830. 107 indexed citations
12.
Enker, Warren E., Howard T. Thaler, Milicent L. Cranor, & Tatyana Polyak. (1995). Total mesorectal excision in the operative treatment of carcinoma of the rectum.. PubMed. 181(4). 335–46. 590 indexed citations breakdown →
13.
Youngson, Bruce, Milicent L. Cranor, & Paul Peter Rosen. (1994). Epithelial Displacement in Surgical Breast Specimens Following Needling Procedures. The American Journal of Surgical Pathology. 18(9). 896–903. 115 indexed citations
14.
Powell, C M, Milicent L. Cranor, & Peter Rosen. (1994). Multinucleated stromal giant cells in mammary fibroepithelial neoplasms. A study of 11 patients.. PubMed. 118(9). 912–6. 36 indexed citations
15.
Hoeven, Karen H. van, Teresa Drudis, Milicent L. Cranor, Robert A. Erlandson, & Paul Peter Rosen. (1993). Low-Grade Adenosquamous Carcinoma of the Breast. The American Journal of Surgical Pathology. 17(3). 248–258. 94 indexed citations
16.
Cranor, Milicent L., et al.. (1993). Carcinoma of the Breast Arising in Microglandular Adenosis. American Journal of Clinical Pathology. 100(5). 507–513. 37 indexed citations
17.
Cranor, Milicent L., et al.. (1993). Papillary duct hyperplasia of the breast in children and young women.. PubMed. 6(5). 570–4. 9 indexed citations
18.
Cranor, Milicent L., et al.. (1992). Atypical Duct Hyperplasia of the Breast in Young Females. The American Journal of Surgical Pathology. 16(3). 246–251. 5 indexed citations
19.
Hoda, Syed A., Milicent L. Cranor, & Paul Peter Rosen. (1992). Hemangiomas of the Breast With Atypical Histological Features Further Analysis of Histological Subtypes Confirming Their Benign Character. The American Journal of Surgical Pathology. 16(6). 553–560. 36 indexed citations
20.
Enker, Warren E., et al.. (1991). DNA/RNA Content and Proliferative Fractions of Colorectal Carcinomas: A Five-Year Prospective Study Relating Flow Cytometry to Survival. JNCI Journal of the National Cancer Institute. 83(10). 701–707. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026